Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.

[1]  E. E. van der Wall,et al.  Dobutamine-induced increase of right ventricular contractility without increased stroke volume in adolescent patients with transposition of the great arteries: Evaluation with magnetic resonance imaging , 2000, The International Journal of Cardiac Imaging.

[2]  R. Lange,et al.  Hearts late after fontan operation have normal mass, normal volume, and reduced systolic function: a magnetic resonance imaging study. , 2003, Journal of the American College of Cardiology.

[3]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol european trial (COMET): randomized controlled trial☆ , 2003 .

[4]  P. Poole‐Wilson,et al.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.

[5]  A. Parkhomenko,et al.  Management of grown up congenital heart disease. , 2003, European heart journal.

[6]  R. Quaife,et al.  Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  Werner Klein,et al.  Management of Grown Up Congenital Heart Disease The Task Force on the Management of Grown Up Congenital Heart Disease of the European Society of Cardiology , 2003 .

[8]  S. Nekolla,et al.  Myocardial Perfusion and Coronary Flow Reserve Assessed by Positron Emission Tomography in Patients after Fontan-like Operations , 2003, Pediatric Cardiology.

[9]  P. Kilner,et al.  Excessive right ventricular hypertrophic response in adults with the mustard procedure for transposition of the great arteries. , 2002, The American journal of cardiology.

[10]  P. Kilner,et al.  Global Impairment of Cardiac Autonomic Nervous Activity Late After Repair of Tetralogy of Fallot , 2002, Circulation.

[11]  A. Wilde,et al.  ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters , 2002, Heart.

[12]  A. Tajik,et al.  Outcome of the unoperated adult who presents with congenitally corrected transposition of the great arteries. , 2002, Journal of the American College of Cardiology.

[13]  S. Anker,et al.  Neurohormonal Activation and the Chronic Heart Failure Syndrome in Adults With Congenital Heart Disease , 2002, Circulation.

[14]  E. E. van der Wall,et al.  Comparable systemic ventricular function in healthy adults and patients with unoperated congenitally corrected transposition using MRI dobutamine stress testing. , 2002, The Annals of thoracic surgery.

[15]  S. Masutani,et al.  Ventricular Afterload and Ventricular Work in Fontan Circulation: Comparison With Normal Two-Ventricle Circulation and Single-Ventricle Circulation With Blalock-Taussig Shunts , 2002, Circulation.

[16]  S. Siu,et al.  Heart Failure and Ventricular Dysfunction in Patients With Single or Systemic Right Ventricles , 2002, Circulation.

[17]  H. Sugiyama,et al.  Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  E. Foster,et al.  Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. , 2001, The American journal of cardiology.

[19]  B. Mulder,et al.  Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the Management of Adults with Congenital Heart Disease--Part II. , 2001, The Canadian journal of cardiology.

[20]  H. Ohuchi,et al.  Severely Impaired Cardiac Autonomic Nervous Activity After the Fontan Operation , 2001, Circulation.

[21]  F. Meijboom,et al.  CCS Consensus Conference 2001 update: recommendations for the management of adults with congenital heart disease. Part I. , 2001, The Canadian journal of cardiology.

[22]  W. Williams,et al.  The Fontan procedure in adults , 2001, Heart.

[23]  A. Wessel,et al.  Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol. , 2001, International journal of cardiology.

[24]  D. DeMets,et al.  Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.

[25]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[26]  Geoffrey I. Webb,et al.  Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. , 2001, The American journal of cardiology.

[27]  A. Redington,et al.  Failure of Stroke Volume Augmentation During Exercise and Dobutamine Stress Is Unrelated to Load-Independent Indexes of Right Ventricular Performance After the Mustard Operation , 2000, Circulation.

[28]  A. Wessel,et al.  Effectiveness of low dose captopril versus propranolol therapy in infants with severe congestive failure due to left-to-right shunts. , 2000, International journal of cardiology.

[29]  J. Różański,et al.  Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up. , 2000, Journal of the American College of Cardiology.

[30]  A. Dilenarda,et al.  [Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[31]  Y. Mori,et al.  Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study. , 2000, Journal of the American College of Cardiology.

[32]  I. Gessner,et al.  Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. , 2000, Journal of the American College of Cardiology.

[33]  E. Jaeggi,et al.  Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries. , 2000, Journal of the American College of Cardiology.

[34]  O. K. Hansen,et al.  Neurohormonal activation late after cavopulmonary connection , 2000, Heart.

[35]  H. Ogino,et al.  beta-blocker therapy in patients after aortic valve replacement for aortic regurgitation. , 2000, International journal of cardiology.

[36]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[37]  M. Bristow.  β-Adrenergic Receptor Blockade in Chronic Heart Failure , 2000 .

[38]  S. Yusuf,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .

[39]  A. Aljada,et al.  Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids. , 2000, Circulation.

[40]  R. Lewin.  Return to work after MI, the roles of depression, health beliefs and rehabilitation. , 1999, International journal of cardiology.

[41]  S. Frøland,et al.  Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure. , 1999, Journal of the American College of Cardiology.

[42]  L. Mahony,et al.  Is captopril useful in decreasing pleural drainage in children after modified Fontan operation? , 1999, The American journal of cardiology.

[43]  E. Jaeggi,et al.  Right ventricular dysfunction in congenitally corrected transposition of the great arteries. , 1999, The American journal of cardiology.

[44]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[45]  Geoffrey I. Webb,et al.  Arrhythmia and survival in patients >18 years of age after the mustard procedure for complete transposition of the great arteries. , 1999, The American journal of cardiology.

[46]  J. Happonen,et al.  Late results of Senning operation. , 1999, The Journal of thoracic and cardiovascular surgery.

[47]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[48]  A. Ciampi,et al.  Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study. , 1998, European heart journal.

[49]  D. Pimentel,et al.  Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. , 1998, Circulation.

[50]  P. Schwartz,et al.  The autonomic nervous system and sudden death. , 1998, European heart journal.

[51]  R. Buchhorn,et al.  Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts. , 1998, The American journal of cardiology.

[52]  D. Alehan,et al.  Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms. , 1998, American heart journal.

[53]  E. Ohlstein,et al.  CARVEDILOL INHIBITS ENDOTHELIN-1 BIOSYNTHESIS IN CULTURED HUMAN CORONARY ARTERY ENDOTHELIAL CELLS , 1998 .

[54]  L. Mahony,et al.  Enalapril does not enhance exercise capacity in patients after Fontan procedure. , 1997, Circulation.

[55]  M. Bristow,et al.  Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.

[56]  G. Zhao,et al.  Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. , 1996, Circulation research.

[57]  Y. Watanabe,et al.  Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease. , 1996, Clinical nephrology.

[58]  D. Kelly,et al.  Angiotensin-converting enzyme inhibitors in adults with cyanotic congenital heart disease. , 1996, The American journal of cardiology.

[59]  R. Hurwitz,et al.  Right ventricular systolic function in adolescents and young adults after Mustard operation for transposition of the great arteries. , 1996, The American journal of cardiology.

[60]  P. Grayburn,et al.  Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. , 1995, Journal of the American College of Cardiology.

[61]  W. Williams,et al.  Ventricular performance before and after Fontan repair for univentricular atrioventricular connection: angiographic and radionuclide assessment. , 1992, Journal of the American College of Cardiology.

[62]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[63]  B. Parsons,et al.  Adrenergic Effects on the Biology of the Adult Mammalian Cardiocyte , 1992, Circulation.

[64]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[65]  K. Weber,et al.  Pathological Hypertrophy and Cardiac Interstitium: Fibrosis and Renin‐Angiotensin‐Aldosterone System , 1991, Circulation.

[66]  G. Lamas,et al.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. , 1988, The New England journal of medicine.

[67]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.